Parental awareness and utilization of meningococcal serogroup B vaccines in the United States

BMC Public Health. 2020 Jul 14;20(1):1109. doi: 10.1186/s12889-020-09181-8.

Abstract

Background: Meningococcal serogroup B (MenB) is the most common cause of invasive meningococcal disease (IMD) in the United States. The US Advisory Committee on Immunization Practices (ACIP) recommends vaccination of healthy adolescents against MenB based on shared clinical decision-making (Category B recommendation). This survey assessed factors associated with MenB vaccine awareness, utilization, and interest among parents/guardians of US adolescents.

Methods: Survey participants were identified in 2016 through KnowledgePanel®, an online random sample of US households; population-based weighting methodology was used to ensure data reflected a demographically representative population sample. Adults with ≥1 dependent aged 16-19 years were eligible and completed an online questionnaire. Respondents were grouped in terms of MenB vaccination of their child as: 1) vaccinated, 2) intending to vaccinate, 3) MenB vaccine-unaware, or 4) vaccine-aware but not intending to vaccinate. Univariate and multivariate analyses were used to identify factors influencing MenB vaccine awareness and utilization; univariate analyses used the weighted proportion of each group or weighted means, and multivariate analyses used logistic regression models based on the weighted study sample of each group.

Results: Six hundred nineteen parents/guardians participated, corresponding to 26,266,700 members of the US population after weighting. MenB vaccine awareness was significantly associated with parent race and sex. Specifically, 57% of parents were unaware of MenB vaccines, and there was significantly higher lack of awareness among males and those of Hispanic or non-White ethnicity. In addition, 36% of unaware parents/guardians were interested in and seeking MenB vaccine information from their healthcare provider (HCP), and there was higher interest among parents of Hispanic ethnicity. 'Vaccinated/intending to vaccinate' versus 'not intending to vaccinate' and 'vaccinated' versus 'intending to vaccinate' were both strongly associated with whether an HCP had recommended vaccination (odds ratios, 4.81 [95% CI 2.46, 9.35] and 5.66 [95% CI 2.46, 12.87], respectively).

Conclusions: Racial and socioeconomic disparities exist in the awareness and utilization of MenB vaccines among parents/guardians of US adolescents. HCP discussion and recommendation are critical catalysts for MenB vaccination and underscore the need to accurately interpret and implement the shared clinical decision-making (Category B) recommendation.

Keywords: Adolescents; Category B recommendation; Meningococcal disease; Meningococcal serogroup B; Racial disparities; Socioeconomic disparities; Vaccination; Vaccine awareness.

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Immunization / psychology*
  • Immunization / statistics & numerical data
  • Male
  • Meningococcal Infections / prevention & control*
  • Meningococcal Vaccines / administration & dosage*
  • Neisseria meningitidis, Serogroup B / immunology*
  • Parents / psychology*
  • Surveys and Questionnaires
  • United States
  • Vaccination / psychology*
  • Vaccination / statistics & numerical data

Substances

  • Meningococcal Vaccines

Grants and funding